The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 17.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (2 analysts) rates it none, with a mean price target of $44.
La-Z-Boy Incorporated
LZB · the NYSE · USD · Market cap $1.3B · 10,600 employees
La-Z-Boy Incorporated manufactures, markets, imports, exports, distributes, and retails upholstery furniture products in the United States, Canada, and internationally.
PASS · Titan Ethical · score 70.0At the last full screen
2026-08-27
Screened 2026-08-27 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its distribution label.
La-Z-Boy Incorporated holds its Distribution at $32.73. Elevated stress, defensive posture warranted, held for 109 days.
| Phase | Distribution · caution |
| Quantitative state | Elevated stress, defensive posture warranted, held for 109 days |
| Price at the screen | $32.73 |
| Valuation | 16.61 trailing · 11.63 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 1.28 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 27.63% | Below 33% | Interest-bearing debt is just 27.6% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 21.26% | Below 49% | Money owed to the company is 21.3% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.56% | Below 5% | Only 0.6% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-08-27 screen. The gold marker is the market price at the same screen. A 28.3% margin of safety to the base estimate.
Third-party analyst targets: 2 covering, consensus Buy. The average target sits +25% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-27 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsRecliner maker stalls with zero revenue growth
Every living room has a favourite chair, yet La-Z-Boy shows no revenue growth and only 5% profit margins at a 12 times forward multiple. The business clears our ethical screen, but flat sales and a 10% return on equity leave little room for excitement even with a modest margin of safety to our fair value.
We pass because this is classic cyclical furniture exposure. Low growth and thin returns suggest peak-cycle earnings rather than a bargain, and an unknown moat offers no protection when housing slows or consumer spending dips.
Risk sits in the cycle itself, where a low multiple often signals trouble ahead rather than value. Two analysts still see a buy, yet the numbers show limited upside from here. Analysis, not advice.
| Forward P/E | 11.6xreasonably valued |
| Trailing P/E | 16.6xreasonably valued |
| EPS, trailing | 1.97 |
| EPS, forward | 2.81 |
| Revenue growth | -3.4%revenue is shrinking |
| Profit margin | 3.9%barely profitable |
| Return on equity | 8.0%a modest return on shareholder capital |
| FCF yield | 13.95% |
| Dividend yield | 251.00% |
| Debt to equity | 0.53moderate, manageable leverage |
| Current ratio | 1.67healthy short-term liquidity |
| Beta | 1.28moves a little more than the market |
| Short interest, float | 0.05% |
| 52-week range | 29.03 - 44.90 |
| Market cap | $1.3B |
| Employees | 10,600 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeLZB trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (2 analysts) rates it none, with a mean price target of $44.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (2 analysts) rates it none, with a mean price target of $44.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $35.21 | +6.5% | $0.24 | $1,072 | +7.2% |
| 2 months | $33.56 | +11.7% | $0.24 | $1,125 | +12.5% |
| 3 months | $32.70 | +14.7% | $0.24 | $1,154 | +15.4% |
| 6 months | $39.17 | -4.3% | $0.48 | $970 | -3.0% |
| 1 year | $40.18 | -6.7% | $0.95 | $957 | -4.3% |
| 2 years | $32.82 | +14.3% | $1.81 | $1,198 | +19.8% |
| 3 years | $26.51 | +41.5% | $2.59 | $1,512 | +51.2% |
| 5 years | $38.42 | -2.4% | $3.94 | $1,079 | +7.9% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever LZB does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.